Vizsgálati helyszín
Metabolic Research Institute, Inc
West Palm Beach, Florida 33401', Egyesült ÁllamokMég nincs intézményhez kötve
- 10futó vizsgálat
- 13lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 24 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis17 vizsgálat
- 2. fázis5 vizsgálat
- 4. fázis1 vizsgálat
- Állapot
- Lezárult12 vizsgálat
- Fut, nem toboroz6 vizsgálat
- Toboroz4 vizsgálat
- Felfüggesztve1 vizsgálat
- Leállították1 vizsgálat
- Fő szponzor
- Eli Lilly and Company7 vizsgálat
- Novo Nordisk A/S6 vizsgálat
- Bayer2 vizsgálat
- Anji Pharma1 vizsgálat
- Aventusoft, LLC.1 vizsgálat
- és még 7
Futó vizsgálatok
Toboroz
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
NCT07817251· 3. fázis· Novo Nordisk A/S· Forrás
Contact: Novo Nordisk
Toboroz
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
NCT07754461· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
NCT07392190· 3. fázis· Eli Lilly and Company· Forrás
Contact: Barry Horowitz, MD (principal investigator)
Fut, nem toboroz
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
NCT07076199· 3. fázis· Novo Nordisk A/S· Forrás
Fut, nem toboroz
A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight
NCT06962280· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
NCT06859268· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
NCT06334133· 3. fázis· vTv Therapeutics· Forrás
Toboroz
PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG
NCT06567795· Aventusoft, LLC.· Forrás
Contact: Alayzah Garcia, BA
Fut, nem toboroz
A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)
NCT06113471· 3. fázis· Incyte Corporation· Forrás
Fut, nem toboroz
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
NCT05556512· 3. fázis· Eli Lilly and Company· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Leállították
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.
NCT06493578· 2. fázis· Vyne Therapeutics Inc.· Forrás
Lezárult
A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes
NCT05901831· 3. fázis· Bayer· Forrás
Lezárult
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
NCT06045221· 3. fázis· Eli Lilly and Company· Forrás
Lezárult
Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia
NCT05889156· 2. fázis· NorthSea Therapeutics B.V.· Forrás
Lezárult
A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)
NCT05823948· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
NCT05803421· 3. fázis· Eli Lilly and Company· Forrás
Lezárult
HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes
NCT05623189· 2. fázis· HighTide Therapeutics (Hong Kong) Limited· Forrás
Lezárult
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
NCT05564039· 4. fázis· Eli Lilly and Company· Forrás
Lezárult
A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes
NCT05254002· 2. fázis· Bayer· Forrás
Lezárult
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec
NCT05352815· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
NCT05259033· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)
NCT05013229· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224
NCT04932512· 2. fázis· Ionis Pharmaceuticals, Inc.· Forrás
Hibát jelzek